Showing results (811-820 of 1,305) with videos related to

Sort By:
Pageof 131
International Journal of Clinical Practice|December 31, 2013
A randomised, prospective double-blind, propiverine-controlled trial of imidafenacin in patients with overactive bladderC Park, J Park, M-S Choo, et al.
Planta Medica|July 27, 1999
(-)-Epiafzelechin: cyclooxygenase-1 inhibitor and anti-inflammatory agent from aerial parts of Celastrus orbiculatusK R Min, B Y Hwang, H S Lim, et al.
Cell Death and Differentiation|August 7, 2004
Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylationY-C Kang, K-M Kim, K-S Lee, et al.
International Journal of Clinical Practice|November 7, 2009
An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasiaM K Kim, J Cheon, K S Lee, et al.
Journal of Medicinal Chemistry|October 30, 1992
Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonistsK A Jacobson, O Nikodijevic, X D Ji, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 7, 2011
Pregnancy outcome after 1st-trimester inadvertent exposure to barium sulphate as a contrast media for upper gastrointestinal tract radiographyB H Han, K S Lee, J Y Han, et al.
Iscience|April 25, 2025
Type I interferon signaling controls the early hematopoietic expansion in response to β-glucanYangsong Xu, Man K S Lee, Nicole A de Weerd, et al.
The American Journal of Psychiatry|December 1, 1996
Individual variation in D2 dopamine receptor occupancy in clozapine-treated patientsD Pickar, T P Su, D R Weinberger, et al.
The European Respiratory Journal|March 31, 2010
Phosphoinositide 3-kinase δ inhibitor suppresses interleukin-17 expression in a murine asthma modelS J Park, K S Lee, S R Kim, et al.
International Journal of Clinical Practice|November 4, 2014
The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double-blind, placebo-controlled phase 2 studyM Song, J H Kim, K-S Lee, et al.
Pageof 131